AVITA Medical (RCEL) Gains from Investment Securities (2024 - 2025)
AVITA Medical's (RCEL) quarterly Gains from Investment Securities came in at -$617000.0 in Q4 2025, down 191.68% YoY from $673000.0 in Q4 2024, and down 1442.5% on a QoQ basis from -$40000.0 in Q3 2025.
AVITA Medical (RCEL) Gains from Investment Securities (2024 - 2025) Analysis & Trends
AVITA Medical (RCEL) has 2 years of Gains from Investment Securities data on file, last reported at -$617000.0 in Q4 2025.
- Quarterly Gains from Investment Securities fell 191.68% year-over-year to -$617000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.2 million (down 898.91% YoY) and the FY2025 annual result came in at -$2.2 million, down 898.91% from the prior year.
- Gains from Investment Securities retreated to -$617000.0 in Q4 2025, from -$40000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $870000.0 in Q1 2024 to a low of -$2.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | AVITA Medical | 310.57 Mn | 299.44 Mn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -617,000.00 |
| Dec 31, 2025 | -617,000.00 |
| Sep 30, 2025 | -40,000.00 |
| Sep 30, 2025 | -40,000.00 |
| Jun 30, 2025 | -1.15 Mn |
| Jun 30, 2025 | -1.15 Mn |
| Mar 31, 2025 | -378,000.00 |
| Mar 31, 2025 | -378,000.00 |
| Dec 31, 2024 | 673,000.00 |
| Dec 31, 2024 | 673,000.00 |
| Sep 30, 2024 | 791,000.00 |
| Sep 30, 2024 | 791,000.00 |
| Jun 30, 2024 | -2.06 Mn |
| Jun 30, 2024 | -2.06 Mn |
| Mar 31, 2024 | 870,000.00 |
| Mar 31, 2024 | 870,000.00 |